|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0002965,
umls-concept:C0005821,
umls-concept:C0016011,
umls-concept:C0021467,
umls-concept:C0021469,
umls-concept:C0027051,
umls-concept:C0030705,
umls-concept:C0035173,
umls-concept:C0037088,
umls-concept:C0039082,
umls-concept:C0247025,
umls-concept:C0443343,
umls-concept:C0475224,
umls-concept:C0597357,
umls-concept:C1273870,
umls-concept:C1416485,
umls-concept:C1514761,
umls-concept:C1549479,
umls-concept:C2603343
|
|
pubmed:issue |
21
|
|
pubmed:dateCreated |
1998-5-21
|
|
pubmed:abstractText |
Antithrombotic therapy improves the prognosis of patients with acute coronary syndromes, yet the syndromes remain a therapeutic challenge. We evaluated tirofiban, a specific inhibitor of the platelet glycoprotein IIb/IIIa receptor, in the treatment of unstable angina and non-Q-wave myocardial infarction.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0028-4793
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
21
|
|
pubmed:volume |
338
|
|
pubmed:owner |
NLM
|
|
pubmed:pagination |
1488-97
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9599103-Aged,
pubmed-meshheading:9599103-Angina, Unstable,
pubmed-meshheading:9599103-Aspirin,
pubmed-meshheading:9599103-Double-Blind Method,
pubmed-meshheading:9599103-Drug Therapy, Combination,
pubmed-meshheading:9599103-Female,
pubmed-meshheading:9599103-Fibrinolytic Agents,
pubmed-meshheading:9599103-Hemorrhage,
pubmed-meshheading:9599103-Heparin,
pubmed-meshheading:9599103-Humans,
pubmed-meshheading:9599103-Incidence,
pubmed-meshheading:9599103-Male,
pubmed-meshheading:9599103-Middle Aged,
pubmed-meshheading:9599103-Myocardial Infarction,
pubmed-meshheading:9599103-Myocardial Ischemia,
pubmed-meshheading:9599103-Platelet Aggregation Inhibitors,
pubmed-meshheading:9599103-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:9599103-Proportional Hazards Models,
pubmed-meshheading:9599103-Tyrosine
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
